431 related articles for article (PubMed ID: 29669525)
21. Alterations in Abundance and Compartmentalization of miRNAs in Blood Plasma Extracellular Vesicles and Extracellular Condensates during HIV/SIV Infection and Its Modulation by Antiretroviral Therapy (ART) and Delta-9-Tetrahydrocannabinol (Δ
Kopcho S; McDew-White M; Naushad W; Mohan M; Okeoma CM
Viruses; 2023 Feb; 15(3):. PubMed ID: 36992332
[TBL] [Abstract][Full Text] [Related]
22. Identification of differentially expressed miRNAs in serum extracellular vesicles (EVs) of Kazakh sheep at early pregnancy.
Sun Y; Xu M; Gao R; Xie S; Sun X; He J; Chen X; Li Q; Lu S; Yang M; Li M; Yang H; Huang T; Sun J
Reprod Domest Anim; 2021 May; 56(5):713-724. PubMed ID: 33547667
[TBL] [Abstract][Full Text] [Related]
23. Salivary Circular RNAs Hsa_Circ_0001874 and Hsa_Circ_0001971 as Novel Biomarkers for the Diagnosis of Oral Squamous Cell Carcinoma.
Zhao SY; Wang J; Ouyang SB; Huang ZK; Liao L
Cell Physiol Biochem; 2018; 47(6):2511-2521. PubMed ID: 29991057
[TBL] [Abstract][Full Text] [Related]
24. Salivary microRNAs in oral cancer.
Zahran F; Ghalwash D; Shaker O; Al-Johani K; Scully C
Oral Dis; 2015 Sep; 21(6):739-47. PubMed ID: 25784212
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA expression patterns in oral squamous cell carcinoma: hsa-mir-99b-3p and hsa-mir-100-5p as novel prognostic markers for oral cancer.
Jakob M; Mattes LM; Küffer S; Unger K; Hess J; Bertlich M; Haubner F; Ihler F; Canis M; Weiss BG; Kitz J
Head Neck; 2019 Oct; 41(10):3499-3515. PubMed ID: 31355988
[TBL] [Abstract][Full Text] [Related]
26. Altered levels of miR-21, miR-125b-2*, miR-138, miR-155, miR-184, and miR-205 in oral squamous cell carcinoma and association with clinicopathological characteristics.
Manikandan M; Deva Magendhra Rao AK; Rajkumar KS; Rajaraman R; Munirajan AK
J Oral Pathol Med; 2015 Nov; 44(10):792-800. PubMed ID: 25482863
[TBL] [Abstract][Full Text] [Related]
27. CXCL8, MMP12, and MMP13 are common biomarkers of periodontitis and oral squamous cell carcinoma.
Chen X; Lei H; Cheng Y; Fang S; Sun W; Zhang X; Jin Z
Oral Dis; 2024 Mar; 30(2):390-407. PubMed ID: 36321868
[TBL] [Abstract][Full Text] [Related]
28. MiRNAs that target amyloid precursor protein processing machinery in extracellular vesicles and particles derived from oral squamous cells carcinoma.
Galvão F; Rode MP; de Campos PS; Bruch GE; Carregal VM; Massensini AR; Matte BF; Lamers ML; Creczynski-Pasa TB; Siqueira IR
J Oral Pathol Med; 2023 Oct; 52(9):877-884. PubMed ID: 37549991
[TBL] [Abstract][Full Text] [Related]
29. Alterations in miRNA expression patterns in whole blood of OSCC patients.
Ries J; Vairaktaris E; Kintopp R; Baran C; Neukam FW; Nkenke E
In Vivo; 2014; 28(5):851-61. PubMed ID: 25189899
[TBL] [Abstract][Full Text] [Related]
30. miR-200b-3p in plasma is a potential diagnostic biomarker in oral squamous cell carcinoma.
Sun G; Cao Y; Wang P; Song H; Bie T; Li M; Huai D
Biomarkers; 2018 Mar; 23(2):137-141. PubMed ID: 28135849
[TBL] [Abstract][Full Text] [Related]
31. Several miRNAs derived from serum extracellular vesicles are potential biomarkers for early diagnosis and progression of Parkinson's disease.
He S; Huang L; Shao C; Nie T; Xia L; Cui B; Lu F; Zhu L; Chen B; Yang Q
Transl Neurodegener; 2021 Jul; 10(1):25. PubMed ID: 34315539
[TBL] [Abstract][Full Text] [Related]
32. MALAT1 as a potential salivary biomarker in oral squamous cell carcinoma through targeting miRNA-124.
Shalaby R; Ibrahim S; Kotb AAW; Baz S; Hafed L; Shaker O; Afifi S
Oral Dis; 2024 May; 30(4):2075-2083. PubMed ID: 37703315
[TBL] [Abstract][Full Text] [Related]
33. Selective extracellular vesicle exclusion of miR-142-3p by oral cancer cells promotes both internal and extracellular malignant phenotypes.
Dickman CT; Lawson J; Jabalee J; MacLellan SA; LePard NE; Bennewith KL; Garnis C
Oncotarget; 2017 Feb; 8(9):15252-15266. PubMed ID: 28146434
[TBL] [Abstract][Full Text] [Related]
34. miR-200c-3p spreads invasive capacity in human oral squamous cell carcinoma microenvironment.
Kawakubo-Yasukochi T; Morioka M; Hazekawa M; Yasukochi A; Nishinakagawa T; Ono K; Kawano S; Nakamura S; Nakashima M
Mol Carcinog; 2018 Feb; 57(2):295-302. PubMed ID: 28981169
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-29b-3p suppresses oral squamous cell carcinoma cell migration and invasion via IL32/AKT signalling pathway.
He J; Ye W; Kou N; Chen K; Cui B; Zhang X; Hu S; Liu T; Kang L; Li X
J Cell Mol Med; 2020 Jan; 24(1):841-849. PubMed ID: 31680452
[TBL] [Abstract][Full Text] [Related]
36. "Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".
Tarrad NAF; Hassan S; Shaker OG; AbdelKawy M
BMC Oral Health; 2023 Dec; 23(1):994. PubMed ID: 38087258
[TBL] [Abstract][Full Text] [Related]
37. Integrative analysis in oral squamous cell carcinoma reveals DNA copy number-associated miRNAs dysregulating target genes.
Serrano NA; Xu C; Liu Y; Wang P; Fan W; Upton MP; Houck JR; Lohavanichbutr P; Kao M; Zhao LP; Schwartz SM; Chen C; Méndez E
Otolaryngol Head Neck Surg; 2012 Sep; 147(3):501-8. PubMed ID: 22470160
[TBL] [Abstract][Full Text] [Related]
38. Salivary microRNA miR-let-7a-5p and miR-3928 could be used as potential diagnostic bio-markers for head and neck squamous cell carcinoma.
Fadhil RS; Wei MQ; Nikolarakos D; Good D; Nair RG
PLoS One; 2020; 15(3):e0221779. PubMed ID: 32208417
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
Zhu X; Zhang H; Xu J
Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
[TBL] [Abstract][Full Text] [Related]
40. MiR-133a-3p Inhibits Oral Squamous Cell Carcinoma (OSCC) Proliferation and Invasion by Suppressing COL1A1.
He B; Lin X; Tian F; Yu W; Qiao B
J Cell Biochem; 2018 Jan; 119(1):338-346. PubMed ID: 28569392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
